The PREVENT study
Advancing baby gut health
Signup is closed
For babies, parents and for better health
Symptoms linked to the gut keep millions of babies and parents up at night. Let's change that together. The PREVENT study aims to further understand the connection between the gut microbiome during the first years of life and lifestyle, wellbeing and health in Sweden.
Did you know more than 50% of all newborns have gut symptoms? Very often these issues are not resolved. For parents, it can be exhausting and frustrating not knowing what to do when their baby won’t stop crying. Visiting doctors and being told “things will get better with time”, or trying to navigate in a whirlwind of tip articles online without any success, does not make it any easier.
There has been a lot of research in babies' gut health, but there hasn’t been a lot of innovation in the field. We want to take things one step further. For babies, for parents and for better health for future generations.
Uppsala University
🇸🇪 Sweden
COPSAC
🇩🇰 Denmark
University of Antwerp
🇧🇪 Belgium

Why PREVENT
So, why is gut health so important? Well, your baby’s gut is home to billions of microbes with an incredibly important role in health. This is called the gut microbiome, which is linked to common child symptoms like colic and constipation, as well as health risks later in life, like allergy, eczema or asthma.
With the PREVENT study, our goal is to power science to solve and prevent these symptoms, together.
Let's make history together
To achieve our mission, we must first understand the role of the gut in health. The PREVENT study is mapping the link between the child’s gut microbiome and
Lifestyle, wellbeing and health
Crying and stool consistency
... in the Swedish population, in the first year of life.
The focus on crying is a first in history!

Signup for the study is closed
A team of experts
Our combined team has over 1600 publications in this field and experience from top two of the largest child gut microbiome studies in the world:
HELMi in Finland: 1000 children followed for 6 years, University of Helsinki
COPSAC in Denmark: 2000 children followed for 10 or 20 years, with focus on allergy, eczema and asthma

